Tony Recupero, former advisor to NuVasive, Inc., LDR, Invuity, Inc. and Ortho Kinematics, Inc., among others, on their sales and go-to-market strategies, is the new Chief Commercial Officer at SI-BONE, Inc.
According to the July 5, 2016 news release, “Recupero brings extensive knowledge of commercialization strategies, developed through a career including more than 30 years in sales, marketing and executive leadership roles in the medical device and diagnostics industry.”
“Recupero was previously President of Catalyst Performance Advisors, LLC a consulting firm that developed and implemented comprehensive commercialization strategies for medical device and diagnostic clients. Recupero advised clients including NuVasive, LDR, Invuity and OrthoKinematics, among others, on their sales and go-to-market strategies. Prior to Catalyst, Recupero was President and CEO of Baxano, Inc., a medical technology company that developed and sold novel product and procedure solutions to treat lumbar spinal stenosis. During his tenure at Baxano, he grew revenue rapidly to over $9 million while executing a merger with Trans1 to form Baxano Surgical, Inc. Recupero was also previously Vice President of Sales at Kyphon, Inc. where he developed and implemented the company’s sales and marketing strategy, taking the company from pre-commercialization to over $213 million in revenue in five years. At Kyphon, Recupero built a direct sales organization of 225 sales consultants and developed a field based health care specialist education program that is now the industry standard for medical device organizations and established the foundation of growth leading to Kyphon’s eventual $4.2 billion acquisition by Medtronic. Recupero began his career at United States Surgical Corporation where he spent 10 years in various sales and sales management positions. Recupero is a graduate of the Harvard Business School General Manager Program and Kellogg Graduate School of Management Sizing and Structuring Sales Organizations program. He holds a B.A. in Communications from the State University of New York at Albany.”
Asked what he is most looking forward to, Recupero told OTW, “I am very excited to be joining SI-BONE at this inflection point with 40 clinical studies including clinically important Level I data, significant momentum on coverage decisions and committed surgeons supporting our growth in the U.S. and world-wide.”
“As I move into the new position I will work with our sales and marketing teams to leverage our industry leading outcomes data with thought leading surgeons including those I have worked with over the years at Spine-Tech, Kyphon and Baxano.”
